Teledermatology and Modulation of Antibiotic Dose in Acne Vulgaris

University of California, Davis4 enrolled

Overview

To see if teledermatology can be used to reduce antibiotic burden in patients on doxycycline or minocycline for acne vulgaris

The investigators are going to ascertain if antibiotic burden can be reduced with tele dermatology use. There are two arms of the study: 1. Feedback group 2. Non feedback group All subjects will be randomised to either group, all subjects will take photos of their face and answer questions at baseline, visit 2 (1 month), visit 3 (2 months), visit 4 (3 months). The investigators will then use measurements of acne grading (patient grading, investigator global assessment, lesion counting, global acne grading) to reduce/taper antibiotics in the feedback group.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Acne Vulgaris

Interventions

Feedback groupOTHER

Monitoring ability to use teledermatology to modify antibiotic burden

Non Feedback groupOTHER

To use as control to see if antibiotic burden has been reduced in the active feedback group

Eligibility

Sex: ALLMin age: 15 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Subjects aged 15 years and older * Subjects who have been prescribed doxycycline or minocycline by their physician for acne vulgaris but have not initiated treatment yet. Exclusion Criteria: * Subjects who have used isotretinoin in the last 6 weeks * Those who have used oral antibiotics within the last 4 weeks * Those who have been initiated or changed brand of oral contraceptive pill within the last one month. * Those subjects who cannot engage with the teledermatology platform * Prisoners * Adults unable to consent

Locations (1)

UC Davis Department of Dermatology, Clinical Trials Unit

Sacramento, California, United States

Outcomes

Primary Outcomes

Reduced antibiotic use

The difference in antibiotic exposure in the physician feedback group compared to those not receiving feedback

Time frame: Assessed at 4, 8, 12 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.